{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:32:54Z","timestamp":1788067974800,"version":"build-2784847793"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.prro.2024.04.009","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T02:28:41Z","timestamp":1714184921000},"page":"e449-e457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas"],"prefix":"10.1016","volume":"14","author":[{"given":"Divya","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4079-1268","authenticated-orcid":false,"given":"Rituraj","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinodh A.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Langshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon J.","family":"Curl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maguy","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasif","family":"Talpur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Beckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra N.","family":"Yeboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol J.","family":"Ghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9662-1519","authenticated-orcid":false,"given":"Caroline","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2024.04.009_bib0001","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2024.04.009_bib0002","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1259\/bjr\/41321492","article-title":"New developments in MRI for target volume delineation in radiotherapy","volume":"79","author":"Khoo","year":"2006","journal-title":"Br J Radiol"},{"key":"10.1016\/j.prro.2024.04.009_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.626100","article-title":"MR-guided radiotherapy for brain and spine tumors","volume":"11","author":"Maziero","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0004","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7785\/tcrt.2012.500342","article-title":"The potential for an enhanced role for MRI in radiation-therapy treatment planning","volume":"12","author":"Metcalfe","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.prro.2024.04.009_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11060-020-03605-6","article-title":"Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow","volume":"149","author":"Tseng","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0006","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11060-018-2896-3","article-title":"Earliest radiological progression in glioblastoma by multidisciplinary consensus review","volume":"139","author":"Eijgelaar","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11060-012-0997-y","article-title":"Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy","volume":"111","author":"Farace","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0008","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/diagnostics10090676","article-title":"Preradiotherapy progression after surgery of newly diagnosed glioblastoma: Corroboration of new prognostic variable","volume":"10","author":"Lakomy","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.prro.2024.04.009_bib0009","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1215\/15228517-2009-005","article-title":"Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma","volume":"11","author":"Pirzkall","year":"2009","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11060-017-2375-2","article-title":"Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with glioblastoma response assessment in an evolving therapeutic landscape","volume":"134","author":"Ellingson","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0011","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0012","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00062-017-0584-x","article-title":"Incidence of tumour progression and pseudoprogression in high-grade gliomas: A systematic review and meta-analysis","volume":"28","author":"Abbasi","year":"2018","journal-title":"Clin Neuroradiol"},{"key":"10.1016\/j.prro.2024.04.009_bib0013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejca.2021.03.002","article-title":"Evidence-based recommendations on categories for extent of resection in diffuse glioma","volume":"149","author":"Karschnia","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2024.04.009_bib0014","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.prro.2024.04.009_bib0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/COC.0000000000000537","article-title":"Rapid early tumor progression is prognostic in glioblastoma patients","volume":"42","author":"Palmer","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0016","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11060-017-2511-z","article-title":"Early tumor growth between initial resection and radiotherapy of glioblastoma: Incidence and impact on clinical outcomes","volume":"134","author":"Villanueva-Meyer","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0017","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/nop\/npac044","article-title":"Incidence and extent of disease progression on MRI between surgery and initiation of radiotherapy in glioblastoma patients","volume":"9","author":"Kraus","year":"2022","journal-title":"Neuro-Oncol Pract"},{"key":"10.1016\/j.prro.2024.04.009_bib0018","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3174\/ajnr.A4917","article-title":"Preradiotherapy MR imaging: A prospective pilot study of the usefulness of performing an MR examination shortly before radiation therapy in patients with glioblastoma","volume":"37","author":"Maj\u00f3s","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.prro.2024.04.009_bib0019","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas","volume":"9","author":"Brandsma","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0020","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2007.14.8163","article-title":"MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients","volume":"26","author":"Brandes","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.04.009_bib0021","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide versus maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2024.04.009_bib0022","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3390\/biomedicines10071763","article-title":"Small molecules and immunotherapy agents for enhancing radiotherapy in glioblastoma","volume":"10","author":"Matsui","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.prro.2024.04.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.105972","article-title":"Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational study","volume":"196","author":"De Barros","year":"2020","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024000894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024000894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T08:31:56Z","timestamp":1746174716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850024000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1879850024000894"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2024.04.009","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2024.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}